MedPath

MINT-EZETIMIBE

MINT-EZETIMIBE

Approved
DIN Number

02423243

Drug Class

Human

Market Date

Sep 15, 2014

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02423243
AIG Number0149164001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AX09 EZETIMIBE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.05
Health Canada Classification

ACTIVE INGREDIENTS (1)

EZETIMIBEActive
Strength: 10 MG
Monograph: EZETIMIBE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.